Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)
CUPR Stock Price Chart
Explore Cuprina Holdings (Cayman) Limited Class A Ordinary Shares interactive price chart. Choose custom timeframes to analyze CUPR price movements and trends.
CUPR Company Profile
Discover essential business fundamentals and corporate details for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 Apr 2025
Employees
15.00
Website
https://www.cuprina.com.sgCEO
Yong Qi Quek
Description
Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.
CUPR Financial Timeline
Browse a chronological timeline of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 27 May 2026
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 May 2026
CUPR Stock Performance
Access detailed CUPR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
